350 related articles for article (PubMed ID: 25604251)
1. Cysteine-sparing CADASIL mutations in NOTCH3 show proaggregatory properties in vitro.
Wollenweber FA; Hanecker P; Bayer-Karpinska A; Malik R; Bäzner H; Moreton F; Muir KW; Müller S; Giese A; Opherk C; Dichgans M; Haffner C; Duering M
Stroke; 2015 Mar; 46(3):786-92. PubMed ID: 25604251
[TBL] [Abstract][Full Text] [Related]
2. Systematic Review of Cysteine-Sparing NOTCH3 Missense Mutations in Patients with Clinical Suspicion of CADASIL.
Muiño E; Gallego-Fabrega C; Cullell N; Carrera C; Torres N; Krupinski J; Roquer J; Montaner J; Fernández-Cadenas I
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902129
[TBL] [Abstract][Full Text] [Related]
3. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) associated with a novel C82R mutation in the NOTCH3 gene.
Zea-Sevilla MA; Bermejo-Velasco P; Serrano-Heranz R; Calero M
J Alzheimers Dis; 2015; 43(2):363-7. PubMed ID: 25096610
[TBL] [Abstract][Full Text] [Related]
4. Clinical and imaging features of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and cysteine-sparing NOTCH3 mutations.
Kim H; Lim YM; Lee EJ; Oh YJ; Kim KK
PLoS One; 2020; 15(6):e0234797. PubMed ID: 32555735
[TBL] [Abstract][Full Text] [Related]
5. A novel cysteine-sparing G73A mutation of NOTCH3 in a Chinese CADASIL family.
Huang L; Li W; Li Y; Song C; Wang P; Wang H; Sun X
Neurogenetics; 2020 Jan; 21(1):39-49. PubMed ID: 31720972
[TBL] [Abstract][Full Text] [Related]
6. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: two novel mutations in the NOTCH3 gene in Chinese.
Lee YC; Yang AH; Liu HC; Wong WJ; Lu YC; Chang MH; Soong BW
J Neurol Sci; 2006 Jul; 246(1-2):111-5. PubMed ID: 16580020
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of CADASIL in Korea: a novel cysteine-sparing Notch3 mutation.
Kim Y; Choi EJ; Choi CG; Kim G; Choi JH; Yoo HW; Kim JS
Neurology; 2006 May; 66(10):1511-6. PubMed ID: 16717210
[TBL] [Abstract][Full Text] [Related]
8. Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain.
Monet-Leprêtre M; Bardot B; Lemaire B; Domenga V; Godin O; Dichgans M; Tournier-Lasserve E; Cohen-Tannoudji M; Chabriat H; Joutel A
Brain; 2009 Jun; 132(Pt 6):1601-12. PubMed ID: 19293235
[TBL] [Abstract][Full Text] [Related]
9. A novel Notch3 Gly89Cys mutation in a Serbian CADASIL family.
Pavlovic AM; Dobricic V; Semnic R; Lackovic V; Novakovic I; Bajcetic M; Sternic N
Acta Neurol Belg; 2013 Sep; 113(3):299-302. PubMed ID: 23319290
[TBL] [Abstract][Full Text] [Related]
10. Genotype and Phenotype Differences in CADASIL from an Asian Perspective.
Kim Y; Bae JS; Lee JY; Song HK; Lee JH; Lee M; Kim C; Lee SH
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232798
[TBL] [Abstract][Full Text] [Related]
11. Sporadic vascular dementia as clinical presentation of a new missense mutation within exon 7 of NOTCH3 gene.
Pradotto L; Azan G; Doriguzzi C; Valentini C; Mauro A
J Neurol Sci; 2008 Aug; 271(1-2):207-10. PubMed ID: 18499132
[TBL] [Abstract][Full Text] [Related]
12. Considerations on a mutation in the NOTCH3 gene sparing a cysteine residue: a rare polymorphism rather than a CADASIL variant.
Bersano A; Ranieri M; Ciammola A; Cinnante C; Lanfranconi S; Dotti MT; Candelise L; Baschirotto C; Ghione I; Ballabio E; Bresolin N; Bassi MT
Funct Neurol; 2012; 27(4):247-52. PubMed ID: 23597439
[TBL] [Abstract][Full Text] [Related]
13. New mutations in the Notch3 gene in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL).
Abramycheva N; Stepanova M; Kalashnikova L; Zakharova M; Maximova M; Tanashyan M; Lagoda O; Fedotova E; Klyushnikov S; Konovalov R; Sakharova A; Illarioshkin S
J Neurol Sci; 2015 Feb; 349(1-2):196-201. PubMed ID: 25623805
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic NOTCH3 cysteine correction in CADASIL using exon skipping: in vitro proof of concept.
Rutten JW; Dauwerse HG; Peters DJ; Goldfarb A; Venselaar H; Haffner C; van Ommen GJ; Aartsma-Rus AM; Lesnik Oberstein SA
Brain; 2016 Apr; 139(Pt 4):1123-35. PubMed ID: 26912635
[TBL] [Abstract][Full Text] [Related]
15. Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features.
Moccia M; Mosca L; Erro R; Cervasio M; Allocca R; Vitale C; Leonardi A; Caranci F; Del Basso-De Caro ML; Barone P; Penco S
Neurobiol Aging; 2015 Jan; 36(1):547.e5-11. PubMed ID: 25260852
[TBL] [Abstract][Full Text] [Related]
16. Two novel mutations of the NOTCH3 gene in Korean patients with CADASIL.
Kim Y; Kim JS; Kim G; No YJ; Yoo HW
Mutat Res; 2006 Jan; 593(1-2):116-20. PubMed ID: 16256149
[TBL] [Abstract][Full Text] [Related]
17. The R110C mutation in Notch3 causes variable clinical features in two Turkish families with CADASIL syndrome.
Uyguner ZO; Siva A; Kayserili H; Saip S; Altintaş A; Apak MY; Albayram S; Işik N; Akman-Demir G; Taşyürekli M; Oz B; Wollnik B
J Neurol Sci; 2006 Jul; 246(1-2):123-30. PubMed ID: 16730748
[TBL] [Abstract][Full Text] [Related]
18. Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients.
Tikka S; Mykkänen K; Ruchoux MM; Bergholm R; Junna M; Pöyhönen M; Yki-Järvinen H; Joutel A; Viitanen M; Baumann M; Kalimo H
Brain; 2009 Apr; 132(Pt 4):933-9. PubMed ID: 19174371
[TBL] [Abstract][Full Text] [Related]
19. CADASIL with a novel NOTCH3 mutation (Cys478Tyr).
Ozaki K; Irioka T; Ishikawa K; Mizusawa H
J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):e61-2. PubMed ID: 25595846
[TBL] [Abstract][Full Text] [Related]
20. A novel cysteine-sparing NOTCH3 mutation in a Chinese family with CADASIL.
Ge W; Kuang H; Wei B; Bo L; Xu Z; Xu X; Geng D; Sun M
PLoS One; 2014; 9(8):e104533. PubMed ID: 25098330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
